Colistin Use and Its Resistance in Kingdom of Saudi Arabia: A Narrative Review

Journals Menu

Follow SCIRP

ISSN Print: 2164-2648
ISSN Online: 2164-2656
www.scirp.org/journal/aid
E-mail: aid@scirp.org

"Colistin Use and Its Resistance in Kingdom of Saudi Arabia: A Narrative Review"
written by Hani S. Faidah,
published by Advances in Infectious Diseases, Vol.8 No.4, 2018

has been cited by the following article(s):

[1]	Point prevalence survey of antimicrobial use and resistance during the COVID-19 era among hospitals in Saudi Arabia and the implications
	Antibiotics, 2023

[2]	Using culture sensitivity reports to optimize antimicrobial therapy: findings and implications of antimicrobial stewardship activity in a hospital in Pakistan
	Medicina, 2023

[3]	A SYSTEMATIC REVIEW ON COLISTIN: RESISTANCE AND CLINICAL USES
	2022

Follow SCIRP

[1]	An Update on Colistin in Clinical Healthcare Unit in the Kingdom of Saudi Arabia: A Narrative Review Current Pharmaceutical Design, 2024 DOI:10.2174/0113816128303422240723091231